UMB Bank’s Aerie Pharmaceuticals AERI Stock Holding History

UMB Bank’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,000	Closed	-$160K	–	380
2021 Q2	$160K	Hold	10,000	–	–	﹤0.01%	363
2021 Q1	$179K	Hold	10,000	–	–	﹤0.01%	348
2020 Q4	$135K	Sell	10,000 -90	-0.9%	-$1.09K	﹤0.01%	345
2020 Q3	$149K	Hold	10,090	–	–	﹤0.01%	320
2020 Q2	$149K	Sell	10,090 -15	-0.1%	-$222	﹤0.01%	320
2020 Q1	$136K	Hold	10,105	–	–	﹤0.01%	317
2019 Q4	$245K	Hold	10,105	–	–	0.01%	331
2019 Q3	$194	Hold	10,105	–	–	﹤0.01%	366
2019 Q2	$299	Buy	+10,105	New	+$389K	0.01%	310

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

UMB Bank's AERI Position: Q3 2021 in Review

UMB Bank sold out of Aerie Pharmaceuticals (AERI) in Q3 2021, closing a stake of 10,000 shares — an estimated $160K sold.

UMB Bank first reported a position in AERI in Q2 2019 and held it in 9 quarters. The position peaked at $245K in Q4 2019. 137 funds tracked by Wall St. Rank hold AERI as of Q3 2021.

UMB Bank reported no remaining Aerie Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
UMB Bank sold 10,000 Aerie Pharmaceuticals shares in Q3 2021, an estimated $160K.
UMB Bank first reported a position in Aerie Pharmaceuticals in Q2 2019 and held it in 9 quarters.
UMB Bank's Aerie Pharmaceuticals position peaked at $245K in Q4 2019.
137 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2021.

Based on UMB Bank's 13F filing for Q3 2021, filed 18 Oct 2021.